This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Grant, Stefan
| Item Type | Name |
|
Concept
|
Survival Rate
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Etoposide
|
|
Concept
|
Weight Loss
|
|
Concept
|
Clone Cells
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Carcinoma, Lewis Lung
|
|
Concept
|
BCG Vaccine
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Pathology, Molecular
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Carcinoma, Large Cell
|
|
Concept
|
Mitosis
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Genes, ras
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Genes, Neoplasm
|
|
Concept
|
Genes, p53
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Apoptosis
|
|
Concept
|
DNA Polymerase II
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Brain Diseases, Metabolic
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Disease Progression
|
|
Concept
|
Endonucleases
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Ether-A-Go-Go Potassium Channels
|
|
Concept
|
Tea
|
|
Concept
|
Deoxycytidine
|
|
Concept
|
Genes, erbB-1
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Cell Line, Tumor
|
|
Academic Article
|
Phase I study of green tea extract in patients with advanced lung cancer.
|
|
Academic Article
|
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
|
|
Academic Article
|
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.
|
|
Academic Article
|
Non-small cell lung cancer, version 2.2013.
|
|
Academic Article
|
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.
|
|
Academic Article
|
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
|
|
Academic Article
|
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
|
|
Academic Article
|
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
|
|
Academic Article
|
Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
|
|
Academic Article
|
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
|
|
Academic Article
|
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
|
|
Academic Article
|
Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.
|
|
Academic Article
|
Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
|
|
Academic Article
|
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
|